Neutra Corp
Neutra Corp. was incorporated in Nevada on January 11, 2011 to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, we plan to research and bring new technology to the nutraceutical space.
$0.00
+$0.00 (+0.00%)
Price from 4 days ago
The business is unprofitable at the operating level (-437.78% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 26.1% YoY. The question is whether this is cyclical or a structural shift.
ROIC dropped from -192.33% to -196.21%, capital efficiency is deteriorating.
Price History
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$17K
▼ -26.1% YoY
Net Income (TTM)
-$474K
▲ +11.3% YoY
Op. Margin
-1457.11%
▲ +196.4pp YoY
ROIC
-196.21%
▼ -3.9pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$10K
▲ +62.2% YoY
Net Debt
-$692.00
Net Cash Position
Cash & Equiv.
$692.00
3Y CAGR: +119.9%
Continue Research
SourceComputed from the 10-Q filed 15 Dec 2023, covering the period ending 31 Oct 2023, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.
Price from market data, last close as of 15 Oct 2026. Fiscal year ends Jan. Sector medians are approximate S&P 500 benchmarks and update periodically.
Is Neutra (NTRR) overvalued?
Neutra (NTRR)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Neutra scores 40/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.
Frequently asked
Is Neutra a high-quality business?+
Neutra scores 40 out of 100 on Intrinsiqq's quality score, a weighted blend of 5 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a -1,457.1% operating margin and a -196.2% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Is Neutra a good stock to buy right now?+
That depends on valuation and quality together, not either alone. you should weigh NTRR's valuation and scores 40/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.
Related stocks: Medicinal Chemicals & Botanical Products
Spot a number that looks wrong?
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.